B-Lactams Part 2 Flashcards
1
Q
Type I Hypersensitivty
A
- Most important AE for PCNs
- PCN Haptenization is the cause
- Metabolite opens the B-lactam ring and serves as a hapten to cause IgE medicated immune reaction
- Ranges from rash to anaphylaxis
- Blood levels not monitored since PCNs considered safe
2
Q
PCN Cross Sensitivity
A
- Rare cross allergic reactions
- Aminopenicllins < 2%, cephalosporins 3%, Carbapenems < 1%, and monobactams 0%
3
Q
Cephalosporins
A
- Most widely prescribed and largest selling class of B-lactams
- EX: Keflex (Ceohalexin), Omnicef (Cefdinir), Ceftin (Cefuroxime)
- Same MoA as PCNs
- PKPD Efficacy: T>MIC
- Side chain modification allows for increased cell penetration and resistance to B-lactamase
- Water soluble and pH stable
- Useful alternative for those allergic to PCNs
- 5 generations
4
Q
Ceph. Generation Differences
A
- 1st: Don’t cross BBB (cefazolin)
- 2nd: covers important gut anaerobe B. fragilis
- 3rd: drug of choice for S. pneumoniae (Cefotaxime, Ceftriaxone), IV forms reach adequate CNS levels, causes de-repression of chromosomal B-lactamases
- 4th: Cefepime cover P. aeruginosa
- 5th: Ceftaroline (Teflaro) covers MRSA, ONLY CEPHALOSPORIN
5
Q
Ceftriaxone
A
- Metabolized in the liver
- Eliminated in bile and can get “stuck” from portal hypertension
- Biliary sludging in neonates
6
Q
Ceftazidime
A
- Covers important Gram “-“ (P. aeruginosa)
- Doesn’t cover Gram “+”
7
Q
Cephalosporin PK
A
- Low CNS penetration for all oral forms, but parenteral versions of gen. 3 and 4 reach adequate levels
- Elimination: most are eliminated by kidney, Ceftriaxone being an exception
8
Q
Cephalosporin AE/Monitoring
A
- Similar to PCN
- Lower frequency of allergic reactions or hematologic/renal toxicity
- Monitoring: renal fxn, anaphylaxis with first dose, CBCs and LFTs
9
Q
Monobactams
A
- Expected to be resistant to B-lactamases
- Aztreonam is a good alternative when allergic to PCNs
- Potential cross-reactivity with Ceftazidime (side chain)
- No GI absorption, given IV and IM
- Renally excreted
- Active against Gram “-“ organisms like P. aeruginosa
- No activity against Gram “+” and anaerobes
10
Q
Carbapenems
A
- Broadest spectrum
- Gram “+”, Gram “-“, and anaerobe coverage
- Charge characteristics allow access to specific Gram “-“ porins and increases affinity to a broader range of PBP
- Expected to be resistant to B-lactamases
- Used for infections resistant to other B-lactams and enterobacter infections
- ALL associated with seizures (imipenem especially)
- Mero/Imi/Doripenem have anti-pseudomonal activity
- Cross-reactivity reports are variable
11
Q
Primaxin IV
A
- Imipenem + Cilastatin
- Cilastatin prevents degradation of imipenem by dehydropeptidase-I in the kidneys
- Imipenem is a strong B-lactamase inducer
12
Q
Carbapenem Monitoring
A
- Renal fxn
- Signs of anaphylaxis with first dose
- CBCs
- LFTs
- Confusional states
13
Q
Abx Therapy Monitoring
A
- Temperature
- WBC count (differential)
- Repeat cultures
- Symptom progression/resolution
- AE like renal function and LFTs